Section one: Contracting authority
one.1) Name and addresses
Genomics England
One Canada Square
London
E14 5AB
Contact
Zoë Hallam
supplier.engagement@genomicsengland.co.uk
Telephone
+44 2078825030
Country
United Kingdom
Region code
UKI - London
Internet address(es)
Main address
one.3) Communication
Additional information can be obtained from the above-mentioned address
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Accelerated Combined Sample Extraction and Whole Genome Sequencing Service
Reference number
GEL-HE-596-23
two.1.2) Main CPV code
- 71900000 - Laboratory services
two.1.3) Type of contract
Services
two.1.4) Short description
Accelerated and combined provision of sample extraction and whole genome sequencing for up to 80,000 newborn genomes
two.1.6) Information about lots
This contract is divided into lots: No
two.2) Description
two.2.2) Additional CPV code(s)
- 71900000 - Laboratory services
- 73111000 - Research laboratory services
two.2.3) Place of performance
NUTS codes
- UKI - London
two.2.4) Description of the procurement
Genomics England is aiming to return any ‘condition suspected’ findings regarding an agreed list of 200+ severe conditions for which there is an intervention available early in childhood to families in a timeframe which enables clinicians to order confirmatory tests and start therapeutic treatment. The optimal timeframe has been assessed as 14 working days, with 7 working days of this allocated to extraction and sequencing.
‘No condition suspected’ findings will be returned directly to participants and will not be subject to target turnaround times. However, as this is not known until sequencing is complete, the net impact is that all sequences should be delivered in the timelines described.
The study aims to develop ‘modular’ evidence for policy makers on sequencing as in other areas. For example, separating the evidence on the performance of specific sequencing platforms to detect a particular range of genomic variation from the evidence on the impact of using screening led by the detection of particular classes of genomic variation. This mirrors the ‘technology agnostic’ approach taken by NHS England in the NHS Genomic Test Directory.
To this end, Genomics England are considering a multi-supplier supply chain approach across technologies during the course of the study that enable the development of this evidence. With this approach the sequencing volumes can be delivered by multiple suppliers using a variety of technologies.
two.2.14) Additional information
Suppliers interested in engaging with Genomics England on this requirement are invited to register at www.genomicsengland.bravosolution.co.uk and apply to project_856.
two.3) Estimated date of publication of contract notice
16 October 2023
Section four. Procedure
four.1) Description
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: No